CD34 and myelodysplastic syndrome: To this end, we analyzed a public transcriptome data of CD34-positive bone marrow cells from MDS patients with DNMT3A, TET2, or ASXL1 mutations, and healthy control subjects (Gene Expression Omnibus accession number: GSE58831).